homepee.com

ÇÐȸ ¹× ÈÄ¿ø

ÇÐȸ ¹× ÈÄ¿ø

¡å

  • CUSTOMER
  • 02-3425-1139
  • am 08:00 ~ pm 06:00
¿Â¶óÀι®ÀÇ
  • Home
  • ÇÐȸ ¹× ÈÄ¿ø
  • ICNIM

ICNIMÇÐȸ ¹× ÈÄ¿ø

Á¦¸ñ Á¦8ȸ AHCC ¿¬±¸È¸ ±¹Á¦È¸ÀÇ
ÀÛ¼ºÀÚ KCFKOREA
ÀÛ¼ºÀÏÀÚ 2019-04-09

 

 
 
 
Á¦8ȸ AHCC ¿¬±¸È¸ ±¹Á¦È¸ÀÇ  
°³ÃÖ Àå¼Ò : »ñÆ÷·Î½Ã(·ÎÀÌÆ° »ñÆ÷·Î)   
ÁÖÃÖ : AHCC ¿¬±¸È¸  
ÈÄ¿ø : ÁÖ½Äȸ»ç ¾Æ¹Ì³ë¾÷È­ÇР
 
 

ÇÑ ÇØ µ¿¾È AHCC¸¦ ¿¬±¸ÇÏ°í ±× ¼º°ú¸¦ º¸°íÇÏ´Â AHCC ¿¬±¸È¸ ±¹Á¦È¸ÀÇ°¡
8ȸÂ÷¸¦ ¸Â¾Ò½À´Ï´Ù.
Á¦8ȸ AHCC ¿¬±¸È¸ ±¹Á¦È¸ÀÇ¿¡¼­´Â ÃÑ 20ÆíÀÇ ÀÏ¹Ý °­¿¬ÀÌ ÁøÇàµÇ¾ú½À´Ï´Ù.
¿©·¯ °­¿¬ Áß °¨¿°, µ¿¹° Áúȯ¿¡ °üÇÑ °­¿¬ÀÌ ¸¹Àº ÀÇ·á °ü°èÀÚµéÀÇ Èï¹Ì¸¦ À¯¹ßÇß½À´Ï´Ù.
°¨¿°°ú AHCCÀÇ »ó°ü°ü°è¿Í µ¿¹°Áúº´¿¡¼­ AHCCÀÇ Á¢¸ñ¿¡ ´ëÇÑ »õ·Î¿î °¡´É¼ºÀ» ½Ã»çÇÏ¿´½À´Ï´Ù.
 
 
 
General Lecture

General Lecture
¡°GCP: Genistein concentrated polysaccharide with anti-angiogenesis and anti-tumor activities in vitro and in vivo¡±
Lan Yuan, et al. £¨Amino Up Chemical Co., Ltd., Japan£©

¡°Studies on the inhibition of angiogenesis by GCP.¡±
Paul F. Davis, et al. £¨Wellington School of Medicine, New Zealand£©

¡°Various effects of the co-administration of AHCC and GCP in vitro and in vivo¡±
Buxiang Sun, et al. £¨Amino Up Chemical Co., Ltd., Japan£©

¡°Isoflavone, BRM and cancers¡±
Robert M. Hackman £¨University of California, Davis, USA£©

¡°Introduction of GCP studies conducted at Colombia University.¡±
Michel Kiernan, et al. £¨Colombia University, USA£©

¡°Preventive effect of AHCC on oxidative stress¡±
Shigeru Matsuzaki, et al. £¨Dokkyo University School of Medicine£©

¡°Preliminary report: Experience of AHCC on progressive, residual and recurrent cancer¡±
Masaru Hagiwara, et al. £¨St.Mariana Medical University, Japan£©

¡°Cancer Immunotherapy by Phyto-polysaccharide (AHCC):Its Effects and Strategy¡±
Katsuaki Uno, et al. £¨Comfort Hospital, Japan£©

¡°Inflammation Regulatory Effect of AHCC¡±
Satoshi Yui, et al. £¨Teikyo University, Japan£©

¡°Preventive effect of AHCC on opportunisitic infection and its mechanism¡±
Shigeru Abe, et al. £¨Teikyo University, Japan£©

¡°Augmentation canine of cellular immune response by administration of AHCC¡±
Tadashi Takahashi, et al. £¨Nihon University, Japan£©

¡°Application of the new immunotherapy using AHCC for animal disease I¡±
Ayako Matuo, et al. £¨Nihon University, Japan£©

¡°Application of the new immunotherapy using AHCC for animal disease II¡±
Takashi Masuyama, et al. £¨Nihon University, Japan£©

¡°Combination of AHCC and chemotherapy¡±
Masuo Hosokawa, et al. £¨Hokkaido University, Japan£©

¡°A clinical study for AHCC on chronic hepatitis patients¡±
Mitsuaki Iwamoto £¨Ensannkai hospital, Japan£©

¡°Effects of AHCC as a complementary treatment for postoperative hepatocellular carcinoma patients¡±
Yoichi Matsui, et al. £¨Kansai Medical University, Japan£©

¡°Case report: Inhibition of liver cirrhosis progression in a case of C type hepatitis with hepatocellular carcinoma¡±
Morihiko Ishizaki, et al. £¨Kansai Medical University, Japan£©

¡°Effect of AHCC on digestive cancer¡¡−especially for terminal cancer−¡±
Yusai Kawaguchi, et al. £¨Kansai Medical University, Japan£©

¡°Prospective,Randomized,Clinical Evaluation of QOL & Immune Index of Advanced, Metastatic Cancer Patients¡±
Gye Hoon Ahn, et al. £¨Ok-Chern love Hospital, Korea£©

¡°Role of AHCC as a Part of an Adult Disease Treatment Protocol¡±
Fred Pescatore £¨The Centers for Integrative and Complementary Medicine, USA£©

 
 
 
 
Á¶È¸¼ö 253

INFORMATION
  • ȸ»ç¸í : ÄÉÀ̾¾¿¡ÇÁÄÚ¸®¾Æ
  • ´ëÇ¥ÀÚ¸í : ±è°ÇÁ¾
  • ÁÖ¼Ò : ¼­¿ï½Ã ±¤Áø±¸ ¶Ò¼¶·Î 700, 202È£
  • ´ëÇ¥ÀüÈ­ : 02-3425-1139
  • ´ëÇ¥ÀüÈ­ : 02-3425-1139
LICENCE
  • »ç¾÷ÀÚµî·Ï¹øÈ£ : 220-81-86504
WEB MASTER
  • e-mail : customer@kcfkorea.com
  • °³ÀÎÁ¤º¸º¸È£Á¤Ã¥ Ã¥ÀÓÀÚ : ±è¸íÈñ
SITEMAP
¸ðµç ÄÁÅÙÃ÷ÀÇ ¹«´ÜÀüÁ¦ ¹× ¸µÅ©¸¦ ±ÝÁöÇÕ´Ï´Ù.
Copyright(c) 1989 by KCFKOREA All Rights Reserved. Designed by www.raphaheal.com